P2 Science Overview
- Year Founded
-
2011
- Status
-
Private
- Employees
-
36
- Latest Deal Type
-
Later Stage VC
- Latest Deal Amount
-
$23M
- Investors
-
22
P2 Science General Information
Description
Developer of specialty chemical products designed to be used in the production of diversified green chemicals. The company's chemicals are produced on intensified process technologies for converting renewable feedstocks into value, specialty chemicals, including flavor and fragrance ingredients, cosmetics ingredients and renewable monomers, enabling businesses to decarbonize the chemical industry, using the power of sustainable resources.
Contact Information
Website
www.p2science.comCorporate Office
- 4 Research Drive
- Woodbridge, CT 06525
- United States
Corporate Office
- 4 Research Drive
- Woodbridge, CT 06525
- United States
P2 Science Timeline
P2 Science Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 17. Later Stage VC | 14-May-2026 | $23M | Completed | Generating Revenue | ||
| 16. Accelerator/Incubator | Completed | Generating Revenue | ||||
| 15. Later Stage VC | 17-Mar-2025 | Completed | Generating Revenue | |||
| 14. Later Stage VC (Series C3) | 27-Nov-2024 | Completed | Generating Revenue | |||
| 13. Later Stage VC (Series C3) | 23-Feb-2023 | Completed | Generating Revenue | |||
| 12. Later Stage VC (Series C3) | 18-Nov-2022 | Completed | Generating Revenue | |||
| 11. Later Stage VC (Series C2) | 29-Jan-2021 | Completed | Generating Revenue | |||
| 10. Debt - General | 08-Jun-2020 | Completed | Generating Revenue | |||
| 9. Later Stage VC (Series C) | 18-Nov-2019 | $15.6M | $31.1M | Completed | Generating Revenue | |
| 8. Later Stage VC (Series B) | 10-Feb-2017 | $11.3M | $15.5M | Completed | Generating Revenue |
P2 Science Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series C-2 | ||||||||
| Series C-1B | ||||||||
| Series C-1A | ||||||||
| Series B | 23,649,230 | $0.001000 | 8% | $0.52 | $0.52 | $0.52 | 30.31% | |
| Series A | 4,883,240 | $0.001000 | 8% | $0.84 | $0.84 | $0.84 | 6.26% |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
P2 Science Comparisons
Industry
Financing
Details
P2 Science Competitors (8)
One of P2 Science’s 8 competitors is INOLEX, a Private Debt Financed company based in Philadelphia, PA.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| INOLEX | Private Debt Financed | Philadelphia, PA | ||||
| Vigon International | Private Equity-Backed | East Stroudsburg, PA | ||||
| Amyris (Biotechnology) | Private Equity-Backed | Emeryville, CA | ||||
| International Flavors & Fragrances | Corporation | New York, NY | ||||
| Ecovia Bio | Venture Capital-Backed | Livonia, MI |
P2 Science Patents
P2 Science Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2025255253-A1 | Novel ester compounds | Pending | 04-Jun-2024 | ||
| WO-2025255257-A1 | Terpene alcohol ester compounds | Pending | 04-Jun-2024 | ||
| EP-4662194-A1 | New method for ozonolysis and reductive quenching of ozonides | Pending | 06-Feb-2023 | ||
| US-20260225982-A1 | New method for ozonolysis and reductive quenching of ozonides | Pending | 06-Feb-2023 | ||
| WO-2024167957-A1 | New method for ozonolysis and reductive quenching of ozonides | Inactive | 06-Feb-2023 | C07C45/40 |
P2 Science Signals
P2 Science Investors (22)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Cycle Capital Management | Venture Capital | Minority | ||
| Emerald Technology Ventures | Venture Capital | Minority | ||
| GS Futures | Corporate Venture Capital | Minority | ||
| Sofinnova Partners | Venture Capital | Minority | ||
| Cambridge Associates | PE-Backed Company | Minority |
P2 Science FAQs
-
When was P2 Science founded?
P2 Science was founded in 2011.
-
Where is P2 Science headquartered?
P2 Science is headquartered in Woodbridge, CT.
-
What is the size of P2 Science?
P2 Science has 36 total employees.
-
What industry is P2 Science in?
P2 Science’s primary industry is Specialty Chemicals.
-
Is P2 Science a private or public company?
P2 Science is a Private company.
-
What is P2 Science’s current revenue?
The current revenue for P2 Science is .
-
How much funding has P2 Science raised over time?
P2 Science has raised $73.1M.
-
Who are P2 Science’s investors?
Cycle Capital Management, Emerald Technology Ventures, GS Futures, Sofinnova Partners, and Cambridge Associates are 5 of 22 investors who have invested in P2 Science.
-
Who are P2 Science’s competitors?
INOLEX, Vigon International, Amyris (Biotechnology), International Flavors & Fragrances, and Ecovia Bio are some of the 8 competitors of P2 Science.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process